![]() Epigenomics Epigenomics AG isa molecular diagnostics company developing and manufacturinga pipeline of products for the diagnosis of cancer. | ![]() Biomatrica Biomatrica: The Biostability Company. We are the leaders at stabilizing biological samples and assays at ambient temperature. | ![]() Indi Molecular Indi Molecular is an emerging life sciences company that is developing a synthetic class of diagnostic and therapeutic agents with antibody-like properties: protein-catalyzed capture agents. | |||
Founding Date | Founding Date 1998 | Founding Date 2004 | Founding Date 2013 | Founding Date 2002 | Founding Date 2010 |
Type | Type Public | Type Subsidiary | Type Private | Type Private | Type Public |
Tags | |||||
Locations | Locations Berlin, DE HQ San Diego, US | Locations San Diego, US HQ | Locations Culver City, US HQ | Locations Nugegoda, LK HQ | Locations Suwon, KR HQ Shanghai, CN Gurugram, IN Purwakarta, ID Cheongwon Gun, KR Gumi, KR Pyeongtaek, KR see more |
Employees | Employees 329% decrease | Employees 109% decrease | Employees 30 | Employees 566% increase | Employees 5952% increase |
Financial | |||||
Revenue (est.) | Revenue (est.) €24k (FY, 2025) | Revenue (est.) N/A | Revenue (est.) N/A | Revenue (est.) N/A | Revenue (est.) ₩710.6b (FY, 2025) |
Cost of goods | Cost of goods N/A | Cost of goods N/A | Cost of goods N/A | Cost of goods N/A | Cost of goods ₩347.9b (FY, 2025) |
Gross profit | Gross profit €31k (FY, 2025) | Gross profit N/A | Gross profit N/A | Gross profit N/A | Gross profit ₩373.8b (FY, 2025) |
Net income | Net income (€314k) (FY, 2025) | Net income N/A | Net income N/A | Net income N/A | Net income (₩513.4b) (FY, 2025) |
Funding | |||||
Total funding raised | Total funding raised $ 11.7m | Total funding raised $ 9.2m | Total funding raised $ 11.5m | Total funding raised N/A | Total funding raised N/A |

Biomatrica: The Biostability Company. We are the leaders at stabilizing biological samples and assays at ambient temperature.
View company
Indi Molecular is an emerging life sciences company that is developing a synthetic class of diagnostic and therapeutic agents with antibody-like properties: protein-catalyzed capture agents.
View company
Avon Pharmo Chem (Avon PC) is a provider of medical laboratory supplies.
View companySD Biosensor is an in-vitro diagnostic company.
View company